Trademark: 98247548
Word
CRISPR-X
Status
Pending
Status Code
641
Status Date
Thursday, May 9, 2024
Serial Number
98247548
Mark Type
3
Filing Date
Tuesday, October 31, 2023

Trademark Owner History

Classifications
42 Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals
The mark consists of the stylized wording "CRISPR-X".
Color is not claimed as a feature of the mark.

Trademark Events
Nov 3, 2023
New Application Entered
Nov 8, 2023
New Application Office Supplied Data Entered
Nov 9, 2023
Notice Of Design Search Code E-Mailed
May 1, 2024
Assigned To Examiner
May 9, 2024
Non-Final Action E-Mailed
May 9, 2024
Non-Final Action Written
May 9, 2024
Notification Of Non-Final Action E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24